- Tytuł:
- Compensatory evolution of Pseudomonas aeruginosa's slow growth phenotype suggests mechanisms of adaptation in cystic fibrosis.
- Autorzy:
- Źródło:
- Nature communications [Nat Commun] 2021 May 27; Vol. 12 (1), pp. 3186. Date of Electronic Publication: 2021 May 27.
- Typ publikacji:
- Journal Article; Research Support, Non-U.S. Gov't
- Język:
- English
- Imprint Name(s):
- Original Publication: [London] : Nature Pub. Group
- MeSH Terms:
-
Evolution, Molecular*
Anti-Bacterial Agents/*pharmacology
Cystic Fibrosis/*complications
Drug Resistance, Microbial/*genetics
Pseudomonas Infections/*drug therapy
Pseudomonas aeruginosa/*genetics
Adaptation, Physiological/drug effects ; Adaptation, Physiological/genetics ; Anti-Bacterial Agents/therapeutic use ; Bacterial Proteins/genetics ; Cell Proliferation/drug effects ; Cell Proliferation/genetics ; Cystic Fibrosis/drug therapy ; Cystic Fibrosis/immunology ; Cystic Fibrosis/microbiology ; DNA Mutational Analysis ; DNA, Bacterial/genetics ; DNA, Bacterial/isolation & purification ; Directed Molecular Evolution ; Drug Resistance, Microbial/drug effects ; Gene Expression Regulation, Bacterial ; Genetic Fitness/drug effects ; Genome, Bacterial ; Humans ; Lung/immunology ; Lung/microbiology ; Microbial Sensitivity Tests ; Mutation ; Phenotype ; Pseudomonas Infections/immunology ; Pseudomonas Infections/microbiology ; Pseudomonas aeruginosa/drug effects ; Pseudomonas aeruginosa/isolation & purification ; Sputum/microbiology - References:
-
Yang, D., Park, S. Y., Park, Y. S., Eun, H. & Lee, S. Y. Metabolic engineering of Escherichia coli for natural product biosynthesis. Trends Biotechnol. 38, 745–765 (2020). (PMID: 3192434510.1016/j.tibtech.2019.11.007)
Pei, L. & Schmidt, M. Fast-growing engineered microbes: new concerns for gain-of-function research? Front. Genet. 9, 207 (2018). (PMID: 30008734603406510.3389/fgene.2018.00207)
Gallagher, T., Phan, J. & Whiteson, K. Getting our fingers on the pulse of slow-growing bacteria in hard-to-reach places. J. Bacteriol. 200, 1–6 (2018). (PMID: 10.1128/JB.00540-18)
Kopf, S. H. et al. Trace incorporation of heavy water reveals slow and heterogeneous pathogen growth rates in cystic fibrosis sputum. Proc. Natl Acad. Sci. U.S.A 113, E110–E116 (2016). (PMID: 2671574110.1073/pnas.1512057112)
Yang, L. et al. In situ growth rates and biofilm development of Pseudomonas aeruginosa populations in chronic lung infections. J. Bacteriol. 190, 2767–2776 (2008). (PMID: 1815625510.1128/JB.01581-07)
La Rosa, R., Johansen, H. K. & Molin, S. Adapting to the airways: metabolic requirements of Pseudomonas aeruginosa during the infection of cystic fibrosis patients. Metabolites 9, 234 (2019). (PMID: 683525510.3390/metabo9100234)
Rossi, E. et al. Pseudomonas aeruginosa adaptation and evolution in patients with cystic fibrosis. Nat. Rev. Microbiol. 19, 331–342 (2021). (PMID: 3321471810.1038/s41579-020-00477-5)
Bartell, J. A. et al. Evolutionary highways to persistent bacterial infection. Nat. Commun. 10, 629 (2019). (PMID: 30733448636739210.1038/s41467-019-08504-7)
La Rosa, R., Johansen, H. K. & Molin, S. Convergent metabolic specialization through distinct evolutionary paths in Pseudomonas aeruginosa. MBio 9, e00269-18 (2018). (PMID: 29636437589387210.1128/mBio.00269-18)
Eng, R. H., Padberg, F. T., Smith, S. M., Tan, E. N. & Cherubin, C. E. Bactericidal effects of antibiotics on slowly growing and nongrowing bacteria. Antimicrob. Agents Chemother. 35, 1824–1828 (1991). (PMID: 195285224527510.1128/AAC.35.9.1824)
Pontes, M. H. & Groisman, E. A. Slow growth determines nonheritable antibiotic resistance in Salmonella enterica. Sci. Signal. 12, 1–11 (2019). (PMID: 10.1126/scisignal.aax3938)
Muir, M. E., van Heeswyck, R. S. & Wallace, B. J. Effect of growth rate on streptomycin accumulation by Escherichia coli and Bacillus megaterium. J. Gen. Microbiol. 130, 2015–2022 (1984). (PMID: 6432955)
Smirnova, G. V. & Oktyabrsky, O. N. Relationship between Escherichia coli growth rate and bacterial susceptibility to ciprofloxacin. FEMS Microbiol. Lett. 365, 1–6 (2018). (PMID: 10.1093/femsle/fnx254)
Marvig, R. L., Sommer, L. M., Molin, S. & Johansen, H. K. Convergent evolution and adaptation of Pseudomonas aeruginosa within patients with cystic fibrosis. Nat. Genet. 47, 57–64 (2015). (PMID: 2540129910.1038/ng.3148)
Hornischer, K. et al. BACTOME—a reference database to explore the sequence- and gene expression-variation landscape of Pseudomonas aeruginosa clinical isolates. Nucleic Acids Res. 47, D716–D720 (2019). (PMID: 3027219310.1093/nar/gky895)
Dettman, J. R. & Kassen, R. Evolutionary genomics of niche-specific adaptation to the cystic fibrosis lung in Pseudomonas aeruginosa. Mol. Biol. Evol. 38, 663–675 (2021). (PMID: 3289827010.1093/molbev/msaa226)
Klockgether, J., Cramer, N., Fischer, S., Wiehlmann, L. & Tümmler, B. Long-term microevolution of Pseudomonas aeruginosa differs between mildly and severely affected cystic fibrosis lungs. Am. J. Respir. Cell Mol. Biol. 59, 246–256 (2018). (PMID: 2947092010.1165/rcmb.2017-0356OC)
Mao, E. F., Lane, L., Lee, J. & Miller, J. H. Proliferation of mutators in A cell population. J. Bacteriol. 179, 417–422 (1997). (PMID: 899029317871110.1128/jb.179.2.417-422.1997)
Taddei, F. et al. Role of mutator alleles in adaptive evolution. Nature 387, 700–702 (1997). (PMID: 919289310.1038/42696)
Tanaka, M. M., Bergstrom, C. T. & Levin, B. R. The evolution of mutator genes in bacterial populations: the roles of environmental change and timing. Genetics 164, 843–854 (2003). (PMID: 12871898146262410.1093/genetics/164.3.843)
Oliver, A. & Mena, A. Bacterial hypermutation in cystic fibrosis, not only for antibiotic resistance. Clin. Microbiol. Infect. 16, 798–808 (2010). (PMID: 2088040910.1111/j.1469-0691.2010.03250.x)
Oliver, A. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 288, 1251–1253 (2000). (PMID: 1081800210.1126/science.288.5469.1251)
Feliziani, S. et al. Coexistence and within-host evolution of diversified lineages of hypermutable Pseudomonas aeruginosa in long-term cystic fibrosis infections. PLoS Genet. 10, e1004651 (2014). (PMID: 25330091419949210.1371/journal.pgen.1004651)
Rees, V. E. et al. Characterization of hypermutator Pseudomonas aeruginosa isolates from patients with cystic fibrosis in Australia. Antimicrob. Agents Chemother. 63, 1–11 (2019). (PMID: 10.1128/AAC.02538-18)
Marvig, R. L., Johansen, H. K., Molin, S. & Jelsbak, L. Genome analysis of a transmissible lineage of Pseudomonas aeruginosa reveals pathoadaptive mutations and distinct evolutionary paths of hypermutators. PLoS Genet. 9, e1003741 (2013). (PMID: 24039595376420110.1371/journal.pgen.1003741)
Ciofu, O., Riis, B., Pressler, T., Poulsen, H. E. & Høiby, N. Occurrence of hypermutable Pseudomonas aeruginosa in cystic fibrosis patients is associated with the oxidative stress caused by chronic lung inflammation. Antimicrob. Agents Chemother. 49, 2276–2282 (2005). (PMID: 15917521114049210.1128/AAC.49.6.2276-2282.2005)
Mena, A. et al. Genetic adaptation of Pseudomonas aeruginosa to the airways of cystic fibrosis patients is catalyzed by hypermutation. J. Bacteriol. 190, 7910–7917 (2008). (PMID: 18849421259321410.1128/JB.01147-08)
López-Causapé, C. et al. Evolution of the Pseudomonas aeruginosa mutational resistome in an international cystic fibrosis clone. Sci. Rep. 7, 1–15 (2017). (PMID: 10.1038/s41598-017-05621-5)
Tenaillon, O. et al. Tempo and mode of genome evolution in a 50,000-generation experiment. Nature 536, 165–170 (2016). (PMID: 27479321498887810.1038/nature18959)
Schick, A. & Kassen, R. Rapid diversification of Pseudomonas aeruginosa in cystic fibrosis lung-like conditions. Proc. Natl Acad. Sci. U.S.A. 115, 10714–10719 (2018). (PMID: 30275334619650710.1073/pnas.1721270115)
Markussen, T. et al. Environmental heterogeneity drives within-host diversification and evolution of Pseudomonas aeruginosa. MBio 5, e01592–14 (2014). (PMID: 25227464417207210.1128/mBio.01592-14)
Passagem-Santos, D., Zacarias, S. & Perfeito, L. Power law fitness landscapes and their ability to predict fitness. Heredity 121, 482–498 (2018). (PMID: 30190560618003810.1038/s41437-018-0143-5)
Lenski, R. E. Experimental evolution and the dynamics of adaptation and genome evolution in microbial populations. ISME J. 11, 2181–2194 (2017). (PMID: 28509909560736010.1038/ismej.2017.69)
Wiser, M. J., Ribeck, N. & Lenski, R. E. Long-term dynamics of adaptation in asexual populations. Science 342, 1364–1367 (2013). (PMID: 2423180810.1126/science.1243357)
Rossi, E., Falcone, M., Molin, S. & Johansen, H. K. High-resolution in situ transcriptomics of Pseudomonas aeruginosa unveils genotype independent patho-phenotypes in cystic fibrosis lungs. Nat. Commun. 9, 3459 (2018). (PMID: 30150613611083110.1038/s41467-018-05944-5)
Cornforth, D. M. et al. Pseudomonas aeruginosa transcriptome during human infection. Proc. Natl Acad. Sci. U.S.A. 115, E5125–E5134 (2018). (PMID: 29760087598449410.1073/pnas.1717525115)
Cornforth, D. M., Diggle, F. L., Melvin, J. A., Bomberger, J. M. & Whiteley, M. Quantitative framework for model evaluation in microbiology research Using Pseudomonas aeruginosa and cystic fibrosis infection as a test case. MBio 11, 1–16 (2020). (PMID: 10.1128/mBio.03042-19)
Webber, M. A. et al. Clinically relevant mutant DNA gyrase alters supercoiling, changes the transcriptome, and confers multidrug resistance. MBio 4, 1–10 (2013). (PMID: 10.1128/mBio.00273-13)
Raji, A., Zabel, D. J., Laufer, C. S. & Depew, R. E. Genetic analysis of mutations that compensate for loss of Escherichia coli DNA topoisomerase I. J. Bacteriol. 162, 1173–1179 (1985). (PMID: 298718421590010.1128/jb.162.3.1173-1179.1985)
Halfon, Y. et al. Structure of Pseudomonas aeruginosa ribosomes from an aminoglycoside-resistant clinical isolate. Proc. Natl Acad. Sci. U.S.A. 116, 22275–22281 (2019). (PMID: 31611393682525510.1073/pnas.1909831116)
Yoon, S. S. et al. Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis. Dev. Cell 3, 593–603 (2002). (PMID: 1240881010.1016/S1534-5807(02)00295-2)
Vakulskas, C. A., Potts, A. H., Babitzke, P., Ahmer, B. M. M. & Romeo, T. Regulation of bacterial virulence by Csr (Rsm) systems. Microbiol. Mol. Biol. Rev. 79, 193–224 (2015). (PMID: 25833324439487910.1128/MMBR.00052-14)
Dunai, A. et al. Rapid decline of bacterial drug-resistance in an antibiotic-free environment through phenotypic reversion. Elife 8, 1–20 (2019). (PMID: 10.7554/eLife.47088)
Cookson, W. O. C. M., Cox, M. J. & Moffatt, M. F. New opportunities for managing acute and chronic lung infections. Nat. Rev. Microbiol. 16, 111–120 (2018). (PMID: 2906207010.1038/nrmicro.2017.122)
Rohmer, L., Hocquet, D. & Miller, S. I. Are pathogenic bacteria just looking for food? Metabolism and microbial pathogenesis. Trends Microbiol. 19, 341–348 (2011). (PMID: 21600774313011010.1016/j.tim.2011.04.003)
Winstanley, C., O’Brien, S. & Brockhurst, M. A. Pseudomonas aeruginosa evolutionary adaptation and diversification in cystic fibrosis chronic lung infections. Trends Microbiol. 24, 327–337 (2016). (PMID: 26946977485417210.1016/j.tim.2016.01.008)
Moradali, M. F., Ghods, S. & Rehm, B. H. A. Pseudomonas aeruginosa lifestyle: a paradigm for adaptation, survival, and persistence. Front. Cell. Infect. Microbiol. 7, 39 (2017). (PMID: 28261568531013210.3389/fcimb.2017.00039)
Lopatkin, A. J. et al. Bacterial metabolic state more accurately predicts antibiotic lethality than growth rate. Nat. Microbiol. 4, 2109–2117 (2019). (PMID: 31451773687980310.1038/s41564-019-0536-0)
Frimodt-Møller, J. et al. Mutations causing low level antibiotic resistance ensure bacterial survival in antibiotic-treated hosts. Sci. Rep. 8, 12512 (2018). (PMID: 30131514610403110.1038/s41598-018-30972-y)
Francis, V. I. et al. Multiple communication mechanisms between sensor kinases are crucial for virulence in Pseudomonas aeruginosa. Nat. Commun. 9, 2219 (2018).
Henry, R. L., Mellis, C. M. & Petrovic, L. Mucoid Pseudomonas aeruginosa is a marker of poor survival in cystic fibrosis. Pediatr. Pulmonol. 12, 158–161 (1992). (PMID: 164127210.1002/ppul.1950120306)
Rehman, A., Patrick, W. M. & Lamont, I. L. Mechanisms of ciprofloxacin resistance in Pseudomonas aeruginosa: new approaches to an old problem. J. Med. Microbiol. 68, 1–10 (2019). (PMID: 3060507610.1099/jmm.0.000873)
Köhler, T., Harayama, S., Ramos, J. L. & Timmis, K. N. Involvement of Pseudomonas putida RpoN sigma factor in regulation of various metabolic functions. J. Bacteriol. 171, 4326–4333 (1989). (PMID: 266639621020810.1128/jb.171.8.4326-4333.1989)
Viducic, D., Murakami, K., Amoh, T., Ono, T. & Miyake, Y. RpoN promotes Pseudomonas aeruginosa survival in the presence of tobramycin. Front. Microbiol. 8, 839 (2017). (PMID: 28553272542711010.3389/fmicb.2017.00839)
Yang, L. et al. Evolutionary dynamics of bacteria in a human host environment. Proc. Natl Acad. Sci. U.S.A. 108, 7481–7486 (2011). (PMID: 21518885308858210.1073/pnas.1018249108)
Damkiær, S., Yang, L., Molin, S. & Jelsbak, L. Evolutionary remodeling of global regulatory networks during long-term bacterial adaptation to human hosts. Proc. Natl Acad. Sci. U.S.A. 110, 7766–7771 (2013). (PMID: 23610385365141810.1073/pnas.1221466110)
May, T. B. & Chakrabarty, A. M. Pseudomonas aeruginosa: genes and enzymes of alginate synthesis. Trends Microbiol. 2, 151–157 (1994). (PMID: 805517810.1016/0966-842X(94)90664-5)
Khaledi, A. et al. Predicting antimicrobial resistance in Pseudomonas aeruginosa with machine learning‐enabled molecular diagnostics. EMBO Mol. Med. 12, 1–19 (2020). (PMID: 10.15252/emmm.201910264)
Sambrook, J., Fritsch, E. F. & Maniatis, T. Molecular Cloning: A Laboratory Manual (Cold Spring Harbor laboratory press, 1989).
LaCroix, R. A., Palsson, B. O. & Feist, A. M. A model for designing adaptive laboratory evolution experiments. Appl. Environ. Microbiol. 83, 1–14 (2017). (PMID: 10.1128/AEM.03115-16)
Wick, R. R., Judd, L. M., Gorrie, C. L. & Holt, K. E. Unicycler: resolving bacterial genome assemblies from short and long sequencing reads. PLoS Comput. Biol. 13, 1–22 (2017). (PMID: 10.1371/journal.pcbi.1005595)
Kumar, S., Stecher, G. & Tamura, K. MEGA7: molecular evolutionary genetics analysis version 7.0 for bigger datasets. Mol. Biol. Evol. 33, 1870–1874 (2016). (PMID: 2700490410.1093/molbev/msw0548210823)
Huang, H. et al. An integrated genomic regulatory network of virulence-related transcriptional factors in Pseudomonas aeruginosa. Nat. Commun. 10, 1–13 (2019).
Qiu, D., Damron, F. H., Mima, T., Schweizer, H. P. & Yu, H. D. PBAD-based shuttle vectors for functional analysis of toxic and highly regulated genes in Pseudomonas and Burkholderia spp. and other bacteria. Appl. Environ. Microbiol. 74, 7422–7426 (2008). (PMID: 18849445259290410.1128/AEM.01369-08)
Kessler, B., de Lorenzo, V. & Timmis, K. N. A general system to integrate lacZ fusions into the chromosomes of gram-negative eubacteria: regulation of the Pm promoter of the TOL plasmid studied with all controlling elements in monocopy. Mol. Gen. Genet. 233, 293–301 (1992). (PMID: 131849910.1007/BF00587591)
Martínez-García, E., Nikel, P. I., Chavarría, M. & de Lorenzo, V. The metabolic cost of flagellar motion in Pseudomonas putida KT2440. Environ. Microbiol. 16, 291–303 (2014). (PMID: 2414802110.1111/1462-2920.12309)
King, E. O., Ward, M. K. & Raney, D. E. Two simple media for the demonstration of pyocyanin and fluorescin. J. Lab. Clin. Med. 44, 301–307 (1954). (PMID: 13184240)
Sayers, S. et al. Victors: a web-based knowledge base of virulence factors in human and animal pathogens. Nucleic Acids Res. 47, D693–D700 (2019). (PMID: 3036502610.1093/nar/gky999)
Liu, B., Zheng, D., Jin, Q., Chen, L. & Yang, J. VFDB 2019: a comparative pathogenomic platform with an interactive web interface. Nucleic Acids Res. 47, D687–D692 (2019). (PMID: 3039525510.1093/nar/gky1080)
Winsor, G. L. et al. Enhanced annotations and features for comparing thousands of Pseudomonas genomes in the Pseudomonas genome database. Nucleic Acids Res. 44, D646–D653 (2016). (PMID: 2657858210.1093/nar/gkv1227)
Schulz, S. et al. Elucidation of sigma factor-associated networks in Pseudomonas aeruginosa reveals a modular architecture with limited and function-specific crosstalk. PLoS Pathog. 11, 1–21 (2015). (PMID: 10.1371/journal.ppat.1004744) - Substance Nomenclature:
-
0 (Anti-Bacterial Agents)
0 (Bacterial Proteins)
0 (DNA, Bacterial) - Entry Date(s):
- Date Created: 20210528 Date Completed: 20210609 Latest Revision: 20230202
- Update Code:
- 20240105
- PubMed Central ID:
- PMC8160344
- DOI:
- 10.1038/s41467-021-23451-y
- PMID:
- 34045458
- Czasopismo naukowe
Menu główne
Wyszukiwarka
Treść główna
